Expression of the opioid growth factor, [Met5]-enkephalin, and the zeta opioid receptor in head and neck squamous cell carcinoma

Laryngoscope

Volumn 107, Issue 3, 1997, Pages 335-339

  Levin, Roger J ^a   Wu, Yan ^a   McLaughlin, Patricia J ^a   Zagon, Ian S ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; METENKEPHALIN; OPIATE RECEPTOR;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CELL PROLIFERATION; CLINICAL ARTICLE; DNA SYNTHESIS; FEMALE; GENE EXPRESSION; HEAD AND NECK CARCINOMA; HEAD AND NECK SURGERY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CELL MOVEMENT; CELL NUCLEUS; CELL SURVIVAL; CYTOPLASM; DISEASE PROGRESSION; DNA; ENKEPHALIN, METHIONINE; EPITHELIUM; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PREVALENCE; RECEPTORS, OPIOID; SKIN; SURVIVAL RATE; TONGUE;

EID: 0030966845     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199703000-00011     Document Type: Article

References (23)

1. Rice DH, Spiro RH. Current concepts in head and neck cancer. American Cancer Society, 1989:1-3.
2. Brennan JA, Mao L, Hruban RH, et al. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 1995;332:429-35.
3. Grandis JR, Tweardy DJ. The role of peptide growth factors in head and neck carcinoma. Otolaryngol Clin North Am 1992;25:1105-15.
4. Thomas GR, Tubb EE, Sessions RB, et al. Growth factor mRNA expression in human head and neck malignant tumors. Arch Otolaryngol Head Neck Surg 1993;19:1247-52.
5. Sturgis EM, Sacks PG, Masui H, et al. Effects of antiepidermal growth factor receptor antibody 528 on the proliferation and differentiation of head and neck cancer. Otolaryngol Head Neck Surg 1994;111:633-43.
6. Maxwell SA, Sacks PG, Gutterman JU, et al. Epidermal growth factor receptor protein-tyrosine kinase activity in human cell lines established from squamous carcinomas of the head and neck. Cancer Res 1989;49:1130-7.
7. Briskin KB, Fady C, Mickel RA, et al. Inhibition of head and neck squamous cell carcinoma cell lines by transforming growth factor-β. Otolaryngol Head Neck Surg 1995;112:728-34.
8. Hughes CJ, Reed JA, Cabal R, et al. Increased expression of basic fibroblast growth factor in squamous carcinogenesis of the head and neck is less prevalent following smoking cessation. Amer J Surg 1994;168:381-5.
9. Prime SS, Game SM, Matthews JB, et al. Epidermal growth factor and transforming growth factor a characteristics of human oral carcinoma cell lines. Br J Cancer 1994;69:8-15.
10. Yoshida K, Kuniyasu H, Yasui W, et al. Expression of growth factors and their receptors in human esophageal carcinomas: regulation of expression by epidermal growth factor and transforming growth factor α. J Cancer Res Clin Oncol 1993;119:401-7.
11. Grandis JR, Tweardy DJ. Elevated levels of transforming growth factor a and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 1993;53:3579-84.
12. Grandis JR, Tweardy DJ. TGF-α and EGFR in head and neck cancer. J Cell Biochem 1993;(suppl 17F):188-91.
13. Santini J, Formento JL, Francoual M, et al. Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas. Head Neck 1991;13:132-9.
14. Christensen ME, Therkildsen MH, Poulsen SS, et al. Immunoreactive transforming growth factor alpha and epidermal growth factor in oral squamous cell carcinomas. J Pathol 1993;169:323-8.
15. Di Marco E, Albanese E, Benso S, et al. Expression of epidermal growth factor receptor and transforming growth factor α in human larynx carcinoma. Cancer Lett 1992;65:189-99.
16. Christensen ME, Therkildsen MH, Poulsen SS, et al. Transforming growth factor alpha and epidermal growth factor in laryngeal carcinomas demonstrated by immunohistochemistry. Acta Otolaryngol (Stockh) 1993;113:563-7.
17. Janot F, El-Naggar AK, Morrison RS, et al. Expression of basic fibroblast growth factor in squamous cell carcinoma of the head and neck is associated with degree of histologic differentiation. Int J Cancer 1995;64:117-23.
18. Zagon IS, McLaughlin PJ. The role of endogenous opioids and opioid receptors in human and animal cancers. In: Plotnikoff NP, Murgo AJ, Faith RE, Wybran J, eds. Stress and immunity. Caldwell, NJ: CRC Press, 1991:343-56.
19. Zagon IS, McLaughlin PJ. Opioid growth factor receptor in the developing nervous system. In: Zagon IS, McLaughlin PJ, eds. Receptors in the developing nervous system. London: Chapman and Hall, 1993:39-62.
20. Zagon IS, Wu Y, McLaughlin PJ. Opioid growth factor (OGF) inhibits DNA synthesis in mouse tongue epithelium in a circadian rhythm-dependent manner. Am J Physiol 1994;267:R645-52.
21. 5]-enkephalin, and the ζ (zeta) opioid receptor are present in human and mouse skin and tonically act to inhibit DNA synthesis in the epidermis. J Invest Dermatol 1996;106:490-7.
22. Zagon IS, McLaughlin PJ, Goodman SR, et al. Opioid receptors and endogenous opioids in diverse human and animal cancers. J Nat Cancer Inst 1987;79:1059-65.
23. Zagon IS, Isayama T, McLaughlin PJ. Preproenkephalin mRNA expression in the developing and adult rat brain. Mol Brain Res 1994;21:85-98.